tiprankstipranks
Astria Therapeutics price target raised to $28 from $26 at Oppenheimer
PremiumThe FlyAstria Therapeutics price target raised to $28 from $26 at Oppenheimer
1M ago
Astria Therapeutics reports Q3 EPS (42c), consensus (42c)
Premium
The Fly
Astria Therapeutics reports Q3 EPS (42c), consensus (42c)
1M ago
Is ATXS a Buy, Before Earnings?
Premium
Pre-Earnings
Is ATXS a Buy, Before Earnings?
2M ago
Astria Therapeutics, Inc. (ATXS) Q2 Earnings Cheat Sheet
PremiumPre-EarningsAstria Therapeutics, Inc. (ATXS) Q2 Earnings Cheat Sheet
5M ago
Alphabet upgraded, Arm downgraded: Wall Street’s top analyst calls
Premium
The Fly
Alphabet upgraded, Arm downgraded: Wall Street’s top analyst calls
5M ago
Astria Therapeutics initiated with a Buy at TD Cowen
Premium
The Fly
Astria Therapeutics initiated with a Buy at TD Cowen
5M ago
Astria Therapeutics Expands Board, Appoints New Director
PremiumCompany AnnouncementsAstria Therapeutics Expands Board, Appoints New Director
9M ago
Astria Therapeutics appoints Agarwal to board of directors
Premium
The Fly
Astria Therapeutics appoints Agarwal to board of directors
9M ago
Astria Therapeutics price target raised to $22 from $17 at Wedbush
Premium
The Fly
Astria Therapeutics price target raised to $22 from $17 at Wedbush
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100